Oragenics partners with Receptor.AI to boost neurological drug development using AI. Learn how this innovation targets Alzheimer’s and more.
Oragenics announces partnership with Receptor.AI
Oct. 07, 2025 8:41 AM ETOragenics, Inc. (OGEN) StockBy: Soumendra Mukherjee, SA News Editor
Comments
Oragenics (NYSE:OGEN) on Tuesday said that it has collaboreted with Receptor.AI, an artificial intel… [743 chars]
Source: Seeking Alpha | Published: 2025-10-07T12:41:06Z
Credit: Seeking Alpha
